The presence of anti‐centromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis

References

• Williams M. H., Das C., Handler C. E., Akram M. R., Davar J., Denton C. P., et al. Systemic sclerosis associated pulmonary hypertension: improved survival in the current era. Heart 2006; 92: 926–32
   PubMed Web of Science ®Google Scholar
• Girgis R. E., Mathai S. C., Krishnan J. A., Wigley F. M., Hassoun P. M. Long‐term outcome of bosentan treatment in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases. J Heart Lung Transplant 2005; 24: 1626–31
   PubMed Web of Science ®Google Scholar
• Denton C. P., Humbert M., Rubin L., Black C. M. Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open‐label extensions. Ann Rheum Dis 2006; 65: 1336–40
   PubMed Web of Science ®Google Scholar
• de Azevedo A. B., Sampaio‐Barros P. D., Torres R. M., Moreira C. Prevalence of pulmonary hypertension in systemic sclerosis. Clin Exp Rheumatol 2005; 23: 447–54
   PubMedGoogle Scholar
• Koh E. T., Lee P., Gladman D. D., bu‐Shakra M. Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients. Br J Rheumatol 1996; 35: 989–93
   PubMedGoogle Scholar
• McLaughlin V. V. Survival in patients with pulmonary arterial hypertension treated with first‐line bosentan. Eur J Clin Invest 2006; 36((Suppl 3))10–15
   PubMedGoogle Scholar
• Chang B., Wigley F. M., White B., Wise R. A. Scleroderma patients with combined pulmonary hypertension and interstitial lung disease. J Rheumatol 2003; 30: 2398–405
   PubMed Web of Science ®Google Scholar
• Schachna L., Wigley F. M., Chang B., White B., Wise R. A., Gelber A. C. Age and risk of pulmonary arterial hypertension in scleroderma. Chest 2003; 124: 2098–104
   PubMed Web of Science ®Google Scholar
• Steen V., Medsger T. A Jr. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003; 48: 516–22
   PubMed Web of Science ®Google Scholar
• Steen V. Predictors of end stage lung disease in systemic sclerosis. Ann Rheum Dis 2003; 62: 97–9
   PubMedGoogle Scholar
• Hesselstrand R., Ekman R., Eskilsson J., Isaksson A., Scheja A., Ohlin A. K., et al. Screening for pulmonary hypertension in systemic sclerosis: the longitudinal development of tricuspid gradient in 227 consecutive patients, 1992–2001. Rheumatology (Oxford) 2005; 44: 366–71
   PubMedGoogle Scholar
• Mukerjee D., St George D., Knight C., Davar J., Wells A. U., Du Bois R. M., et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology (Oxford) 2004; 43: 461–6
   PubMed Web of Science ®Google Scholar
• Trad S., Amoura Z., Beigelman C., Haroche J., Costedoat N., Boutin L. T., et al. Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease. Arthritis Rheum 2006; 54: 184–91
   PubMed Web of Science ®Google Scholar
• Stupi A. M., Steen V. D., Owens G. R., Barnes E. L., Rodnan G. P., Medsger TA J. r. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum 1986; 29: 515–24
   PubMed Web of Science ®Google Scholar
• Plastiras S. C., Karadimitrakis S. P., Kampolis C., Moutsopoulos H. M., Tzelepis G. E. Determinants of pulmonary arterial hypertension in scleroderma. Semin Arthritis Rheum 2007; 36: 392–6
   PubMedGoogle Scholar
• Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23: 581–90
   PubMed Web of Science ®Google Scholar
• Alarcon‐Segovia D., Cardiel M. H. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 1989; 16: 328–34
   PubMed Web of Science ®Google Scholar
• LeRoy E. C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T. A Jr., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202–5
   PubMed Web of Science ®Google Scholar
• Schurawitzki H., Stiglbauer R., Graninger W., Herold C., Polzleitner D., Burghuber O. C., et al. Interstitial lung disease in progressive systemic sclerosis: high‐resolution CT versus radiography. Radiology 1990; 176: 755–9
   PubMed Web of Science ®Google Scholar
• Fujita J., Yoshinouchi T., Ohtsuki Y., Tokuda M., Yang Y., Yamadori I., et al. Non‐specific interstitial pneumonia as pulmonary involvement of systemic sclerosis. Ann Rheum Dis 2001; 60: 281–3
   PubMedGoogle Scholar
• Plastiras S. C., Karadimitrakis S. P., Ziakas P. D., Vlachoyiannopoulos P. G., Moutsopoulos H. M., Tzelepis G. E. Scleroderma lung: initial forced vital capacity as predictor of pulmonary function decline. Arthritis Rheum 2006; 55: 598–602
   PubMed Web of Science ®Google Scholar
• Afeltra A., Zennaro D., Garzia P., Gigante A., Vadacca M., Ruggiero A., et al. Prevalence of interstitial lung involvement in patients with connective tissue diseases assessed with high‐resolution computed tomography. Scand J Rheumatol 2006; 35: 388–94
   PubMed Web of Science ®Google Scholar
• Nishimura R. A., Miller F. A Jr., Callahan M. J., Benassi R. C., Seward J. B., Tajik A. J. Doppler echocardiography: theory, instrumentation, technique, and application. Mayo Clin Proc 1985; 60: 321–43
   PubMed Web of Science ®Google Scholar
• Simonson J. S., Schiller N. B. Sonospirometry: a new method for noninvasive estimation of mean right atrial pressure based on two‐dimensional echographic measurements of the inferior vena cava during measured inspiration. J Am Coll Cardiol 1988; 11: 557–64
   PubMedGoogle Scholar
• Murata I., Takenaka K., Yoshinoya S., Kikuchi K., Kiuchi T., Tanigawa T., et al. Clinical evaluation of pulmonary hypertension in systemic sclerosis and related disorders. A Doppler echocardiographic study of 135 Japanese patients. Chest 1997; 111: 36–43
   PubMed Web of Science ®Google Scholar
• McQuillan B. M., Picard M. H., Leavitt M., Weyman A. E. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation 2001; 104: 2797–802
   PubMed Web of Science ®Google Scholar
• MacGregor A. J., Canavan R., Knight C., Denton C. P., Davar J., Coghlan J., et al. Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival. Rheumatology (Oxford) 2001; 40: 453–9
   PubMed Web of Science ®Google Scholar
• Hachulla E., Gressin V., Guillevin L., Carpentier P., Diot E., Sibilia J., et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005; 52: 3792–800
   PubMed Web of Science ®Google Scholar
• Steen V. Advancements in diagnosis of pulmonary arterial hypertension in scleroderma. Arthritis Rheum 2005; 52: 3698–700
   PubMedGoogle Scholar
• Hesselstrand R., Scheja A., Shen G. Q., Wiik A., Akesson A. The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis. Rheumatology (Oxford) 2003; 42: 534–40
   PubMed Web of Science ®Google Scholar
• Steen V. D. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005; 35: 35–42
   PubMed Web of Science ®Google Scholar
• Alkotob M. L., Soltani P., Sheatt M. A., Katsetos M. C., Rothfield N., Hager W. D., et al. Reduced exercise capacity and stress‐induced pulmonary hypertension in patients with scleroderma. Chest 2006; 130: 176–81
   PubMed Web of Science ®Google Scholar
• Steen V. D., Ziegler G. L., Rodnan G. P., Medsger T. A Jr. Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum 1984; 27: 125–31
   PubMed Web of Science ®Google Scholar
• Kyndt X., Launay D., Hebbar M., Hatron P. Y., Fournier C., Michon‐Pasturel U., et al. Influence of age on the clinical and biological characteristics of systemic scleroderma. Rev Med Interne 1999; 20: 1088–92
   PubMedGoogle Scholar
• Beretta L., Caronni M., Origgi L., Ponti A., Santaniello A., Scorza R. Hormone replacement therapy may prevent the development of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Scand J Rheumatol 2006; 35: 468–71
   PubMed Web of Science ®Google Scholar
• Scorza R., Caronni M., Bazzi S., Nador F., Beretta L., Antonioli R., et al. Post‐menopause is the main risk factor for developing isolated pulmonary hypertension in systemic sclerosis. Ann N Y Acad Sci 2002; 966: 238–46
   PubMed Web of Science ®Google Scholar
• Chang B., Schachna L., White B., Wigley F. M., Wise R. A. Natural history of mild‐moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma. J Rheumatol 2006; 33: 269–74
   PubMed Web of Science ®Google Scholar
• McGoon M., Gutterman D., Steen V., Barst R., McCrory D. C., Fortin T. A., et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence‐based clinical practice guidelines. Chest 2004; 126: 14S–34S
   PubMed Web of Science ®Google Scholar
• Distler O., Pignone A. Pulmonary arterial hypertension and rheumatic diseases – from diagnosis to treatment. Rheumatology (Oxford) 2006; 45((Suppl 4))iv22–5
   PubMedGoogle Scholar
• Plastiras S. C., Kelekis N., Tzelepis G. E. Magnetic resonance imaging for the detection of myocardial fibrosis in scleroderma. N Engl J Med 2006; 354: 2194–6
   PubMedGoogle Scholar
• Tzelepis G. E., Kelekis N. L., Plastiras S. C., Mitseas P., Economopoulos N., Kampolis C., et al. Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Arthritis Rheum 2007; 56: 3827–36
   PubMed Web of Science ®Google Scholar
• Kahan A., Allanore Y. Primary myocardial involvement in systemic sclerosis. Rheumatology (Oxford) 2006; 45((Suppl 4))iv14–17
   PubMedGoogle Scholar